{
    "clinical_study": {
        "@rank": "38336", 
        "arm_group": {
            "arm_group_label": "Exercise", 
            "arm_group_type": "Other", 
            "description": "obese women who are volunteers for the 3 months exercise programs"
        }, 
        "brief_summary": {
            "textblock": "Glypican4, CTRP3, CTRP5 are emerging novel adipokines mediating obesity and inflammation\n      related disorders. RBP4 and adiponectin are well known important adipokines. Therefore, we\n      examine the circulating levels of theses adipokines in the subjects with or without\n      metabolic syndrome. Furthermore, we tried to clarify the effect of exercise on the\n      circulating these adipokines."
        }, 
        "brief_title": "Glypican4 and CTRP5 in Metabolic Syndrome and the Effect of Exercise on These Adipokines", 
        "completion_date": {
            "#text": "September 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Metabolic Syndrome", 
            "Obesity"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Obesity", 
                "Metabolic Syndrome X"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Women  between  30  and  60 years  of  age  who  had  a  body  mass index (BMI) more\n             than 25 kg/m2\n\n          -  The subjects of metabolic syndrome and age, gender matched non metabolic syndrome\n             among the participants of  Korean SO Study (KSOS) study, which is an ongoing\n             epidemiologic study supported by the Korea Science and Engineering Foundation\n\n        Exclusion Criteria:\n\n          -  participants  had  a  history  of  cardiovascular  disease\n\n          -  any type of diabetes\n\n          -  stage 2 hypertension\n\n          -  malignant disease,  severe  renal,  or  hepatic  disease\n\n          -  Subjects  taking medications that might affect body weight or body composition"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01688622", 
            "org_study_id": "KoreaSO_Exercise"
        }, 
        "intervention": {
            "arm_group_label": "Exercise", 
            "description": "training session consisting of a brief warm-up, followed by an approximately 45-min session of aerobic exercise at an intensity of 60-75% of the age-predicted maximum heart rate (approximately 300 kcal/day) and a 20-min muscle strength train- ing programme (approximately 100 kcal/day), followed by a brief cool-down period.", 
            "intervention_name": "3months Exercise", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 20, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Korea University Guro Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effects of Exercise on Glypican4,CTRP3,5 and RBP4 Levels and Circulating Levels of These Adipokines in the Subjects With or Without Metabolic Syndrome", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "The changes of circulating glypican4 levels after 3 months exercise", 
                "safety_issue": "No", 
                "time_frame": "baseline and 12weeks"
            }, 
            {
                "measure": "The changes of circulating CTRP3 levels after 3 months exercise", 
                "safety_issue": "No", 
                "time_frame": "baseline and 12weeks"
            }, 
            {
                "measure": "The changes of circulating CTRP5 levels after 3 months exercise", 
                "safety_issue": "No", 
                "time_frame": "baseline and 12weeks"
            }, 
            {
                "measure": "The changes of circulating RBP4 levels after 3 months exercise", 
                "safety_issue": "No", 
                "time_frame": "baseline and 12weeks"
            }, 
            {
                "measure": "The changes of circulating adiponectin levels after 3 months exercise", 
                "safety_issue": "No", 
                "time_frame": "baseline and 12weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01688622"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Korea University", 
            "investigator_full_name": "K. M. Choi", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Circulating glypican4 levels in the subjects with or without metabolic syndrome", 
                "safety_issue": "No", 
                "time_frame": "baseline"
            }, 
            {
                "measure": "Circulating CTRP3 levels in the subjects with or without metabolic syndrome", 
                "safety_issue": "No", 
                "time_frame": "baseline"
            }, 
            {
                "measure": "Circulating CTRP5 levels in the subjects with or without metabolic syndrome", 
                "safety_issue": "No", 
                "time_frame": "baseline"
            }, 
            {
                "measure": "Circulating RBP4 levels in the subjects with or without metabolic syndrome", 
                "safety_issue": "No", 
                "time_frame": "baseline"
            }, 
            {
                "measure": "Circulating adiponectin levels in the subjects with or without metabolic syndrome", 
                "safety_issue": "No", 
                "time_frame": "baseline"
            }
        ], 
        "source": "Korea University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Korea University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}